Ignite Creation Date:
2024-05-05 @ 9:26 PM
Last Modification Date:
2024-10-26 @ 10:04 AM
Study NCT ID:
NCT00883415
Status:
COMPLETED
Last Update Posted:
2020-05-21
First Post:
2009-04-16
Brief Title:
Myocardial Glucose Uptake MGU in Patients With Chronic Kidney Disease
Sponsor:
University of Maryland Baltimore
Organization:
University of Maryland Baltimore
Study Overview
Official Title:
A Study to Evaluate the Effect of the Treatment of Anemia on Myocardial Glucose Uptake MGU in Patients With Chronic Kidney Disease
Status:
COMPLETED
Status Verified Date:
2020-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study examines patients with chronic kidney disease-related anemia and measures changes in the metabolism of the heart using FDGPET scanning before and 6 months after their health-care provider has initiated anemia management therapy with the FDA-approved drug darbepoetin alfa Aranesp which is approved for chronic kidney disease-related anemia The investigators hypothesize that the heart has abnormal metabolism with the anemia of chronic kidney disease but this improves after correction of this anemia with darbepoetin alfa
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| Amgen ISS20061907 | None | None | None |